enVVeno Medical Corporation — Cash Flow (NASDAQ:NVNO) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 7.68 M-11.85 M15.62 M18.86 M16.84 M 17.23 M Cash from investing activities 180.29 K-367.89 K34.55 M7.87 M1.33 M 618 K Cash from financing activities 15.07 M57.61 M025.79 M13.64 M 241 K Free cash flow 7.5 M-12.21 M15.5 M18.82 M16.8 M 17.22 M

ニュース

enVVeno Medical社、Nasdaq基準に適合し2800万ドルの現金保有を報告

enVVeno Medical regains Nasdaq compliance, reports $28 million cash

enVVeno Medical announces 1-for-35 reverse stock split

enVVeno Medical、株主総会の定足数要件を改定する付属定款の更新を発表

enVVeno Medical updates bylaws to revise stockholder quorum requirement

なぜRLXテクノロジー株が6%上昇して取引されているのか；こちらがプレマーケットで動いている20銘柄です

enVVeno Medical社の株価、VenoValveに対するFDAの拒否維持を受け急落

enVVeno Medical stock plunges after FDA upholds rejection of VenoValve

Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher - Amaze Holdings (AMEX:AMZE), Cidara Therapeutics (NASDAQ:CDTX)

Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings - Applied Mat (NASDAQ:AMAT), Amaze Holdings (AMEX:AMZE)

Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Binah Capital Group (NASDAQ:BCG), Aspire Biopharma Hldgs (NASDAQ:ASBP)

FDAがenVVeno MedicalのVenoValve承認申請の異議申し立てを却下